Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

arsenic trioxide

(AR-seh-nik try-OK-side)
A drug used to treat acute promyelocytic leukemia that has a certain chromosome abnormality or a fusion gene called PML::RARA. It is used with tretinoin in some newly diagnosed adults. It is also used alone in patients whose cancer has not gotten better or has come back after treatment with other anticancer drugs. Arsenic trioxide is also being studied in the treatment of other types of cancer. Arsenic trioxide damages a fusion protein made by the PML::RARA fusion gene. This may help keep cancer cells from growing and may kill them. Also called Trisenox.
More Information
Search NCI's Dictionary of Cancer Terms